Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://www.testfrwd.me/
COVID-19
HOME TEST FOR COVID-19 WITH DIGITAL FINGERPRINT VERIFICATION
THE FIRST HOME TEST FOR COVID-19 WITH DIGITAL FINGERPRINT VERIFICATION ON THE GLOBAL MARKETS
In collaboration with its partners tFRWD has developed a ground-breaking, innovative, patented Covid-19 testing solution specifically designed to enable pain-free, large-scale, and low-priced testing with a focus on the tourism industry. The test kit is CE-certified and complies with EU and WHO guidelines and regulations.
Enabling events
Quick and convenient, large-scale PCR testing with highest accuracy for events either through digitally proved at-home pre-event testing.
Patent approved
The only patented fully digitalised home test kit available on the global markets.
i was alone here at 3-4 cents where i loaded and have just put them away-dont even look at the pps until over .50-----this was at pennies for months with the writing on the wall-----the other boards im on are vacant like this was but people find it sooner or later--i seem to find boards where i can talk to myself alot---nioce to have company here------tmonkey
We should urgently enlarge the board here. There are far too few members here at i-hub. Things look much better at ceo.ca or Yahoo
Great find. Empower’s CEO isn’t all talk like other companies. He knows how to deliver!!!!
https://ceo.ca/@nasdaq/loop-insights-selected-by-bdg-sports-to-provide-fourth
by @nasdaq on 22 Jan 2021, 06:00
Loop Insights Selected by bdG Sports To Provide Fourth Venue Management Platform In A Live Environment For Paiute Las Vegas Golf Championship
Loop has established a testing partnership with Empower Clinics (CBDT:CSE) (EPWCF:OTC) (8EC:FRA) to provide the company with safe and reliable COVID-19 testing at the Championship.
Spit test for the win
In the Yale study, the saliva tests actually detected the virus more frequently — 81% of the tests came back positive in the first five days of infections, compared to 71% of nasopharyngeal tests. The saliva test also detected more copies of the virus’s genetic material.
i thought there would more of a pop here but cant complain with a buy in at 3-4 cents----the day isnt over and i will sell into further strength today----tmonkey
good news here-im gonna let them have some of mine at open and the am on volume!!---tmonkey
saw that!! -i was gonna let a few go today for the holidays---i hope good news??-----bid and ask in canada up so they thjink positive---ill let some go when it opens again but still have a ton----tmonkey
VANCOUVER, BC, Dec. 17, 2020 /CNW/ - The following issues have been halted by IIROC:
Company: Empower Clinics Inc.
CSE Symbol: CBDT
All Issues: Yes
Reason: At the request of the Company Pending News
back at you with my new one----HYHDF----proceeds form this one go there-----tmonkey
Check out EHVVF 50 mill OS can fly with some pressure
i was asking the same thing at.03-.o4-i was alone a long time on this board with an occasional by passer--i just kept adding and now the pay off--------gotta dig up another one now----tmonkey
How come more eyes aren’t on this?
time to let a few more go-------tmonkey
if this keeps falling i may buy some back----alot of cheap shares still out there that are cashing in on the fear down trend now--most of the cash i took out is going to other sectors---looking for the next rocket ride keeps me busy in these stay at home times!!---------tmonkey
lightened the boat from the open yesterday and got nice prices.-----rest of boat on a free ride here for the future---consolidation is normal here-tmonkey
may let a few go today as i have almost a 10 bagger from the 3s i bt not that long ago----would be a fool not to take some off the table with alot left for the run--fidelity still has a no buy policy for this one!!!---glta------tmonkey
This stock is the next dollar stock out of OTC land
ceo is great---nothing goes straight up every day buit this is sure trying!---tmonkey
Reminds me of cbiif. A lot of potential here. Ceo seems on the ball and the company is just starting to kick it into high gear
im sure there is more to this move---its all about findin em early with a shot of patience----tmonkey
let some of my 3s go for .10----will ride the almost free balance to the next levels------tmonkey
it's an exciting stock at these levels. i bought a ton of cbiif a while ago and that stock exploded. maybe epwcf does the same
was sitting at 3-4 cents forever----now finally out of the bag with alot going for it---if half the story is true this is just the start--i kept buying crypto tickers instead of adding here but have a nice holding--actually after geting my first batch fidelity wouldnt allow buying anymore---after 5 complaints i gave up and it is costing me now!!gl--tmonkey----
I bought in today. Looks exciting. Another CBIIF in the making? Next weeks news could get it really going
finally alive and kicking----it took its good time!!----------tmonkey
Good evening MG, hope all is well, Yes, I like this one.I put it aside for long term.I am here with You. EPWCF Holding Long
GLTY
Waking up.....finally
Empower Clinics Growth Strategy Accelerates With Recent Major Initiatives. Updates Status And Outlook Into 2021
3:31 am ET November 2, 2020 (Accesswire) Print
VANCOUVER BC / ACCESSWIRE / November 2, 2020 / EMPOWER CLINICS INC. Empower Clinics (CBDT:CSE)(EPWCF:OTC)(8EC:FRA) (the "Company" or "Empower"), an integrated healthcare company serving a database of 165,000 patients through clinics in the southwest United States, a telemedicine platform and medical diagnostics laboratory, is pleased to provide shareholders with a status report on many initiatives announced over the past several weeks for the purposes of providing greater visibility into the Company's outlook into 2021.
Steven McAuley, CEO of Empower Clinics stated "2020 is the year that established Empower Clinics as a formidable Health & Wellness Company with a solid foundation and great growth prospects. Given the speed at which we have been moving since I took over the leadership reigns in 2019, it is prudent to take a moment to provide our shareholders with both a current snapshot, as well as, our expectations for continued growth into 2021."
HIGHLIGHTS & UPDATES
2020 Revenue Growth The Company has experienced significant revenue growth over the past year as evidenced by the following results:2019 + 86% To $2.03MQ4 + 217% To $625,000Q1 + 416% To $790,000Q2 + 56% To $923,000
This performance has translated into the following year-to-date in 2020:
Revenue $1.7M vs $745K = 130% GrowthPatient Visits 12,400 vs 5,500 = 125% Growth
Going forward, given the Company's diversification into telemedicine, COVID-19 testing, medical laboratory testing for enterprise customers, and the proposed clinic expansion into Canada, all of which serves to diversify Empower well beyond our Southwestern U.S. clinic operations, going forward "patient visits" will be just one of many of the Company's overall KPI's (Key Performance Indicators).
Kai Medical Laboratory COVID-19 Testing Growth Includes Film & Television Industry Empower completed the closing of the Kai Medical Laboratory acquisition with the signing of the Member Purchase Interest Agreement October 5, 2020 and then subsequently completed the filing of all required regulatory documents with the State of Texas and other regulatory bodies.
The Company is now working through integration and implementing aggressive growth strategies including servicing new COVID-19 testing contracts for the film & television industry and supporting the Sun Valley Health COVID-19 RT-PCR and rapid antibody testing programs in the state of Arizona.
Sun Valley Health COVID-19 Regional Testing Growth Sun Valley Health with the support of Kai Medical Laboratory testing and medical billing capabilities, is expanding its RT-PCR testing with the commencement of drive-up testing for consumers in Mesa, Arizona and within clinic locations. The program allows the Company to provide free COVID-19 testing for consumers with Medicare and Medicaid insurance coverage in Arizona and for consumers who do not have active health insurance coverage in the state.$1,100,000 Proposed Private Placement The previously announced proposed private placement with Mackie Research Capital Corporation as sole agent and sole bookrunner (the "Agent") on October 21, 2020 remains on track for closing as planned on or about the week of November 2, 2020.Canadian Clinic Acquisition The recently announced non-binding term sheet for the acquisition of Lawrence Park Health and Wellness Clinic Inc., 1100900 Canada Inc. dba Atkinson, and Momentum Health Inc. collectively ("Momentum Health") is progressing as planned through the final due diligence phase with an anticipated closing in November 2020.Q3 2020 Financial Statements The Company anticipates filing its third quarter 2020 financial statements and MD&A well in advance of the November 30, 2020 filing deadline. Financial and accounting controls supported by CFO Kyle Appleby enable the Company to maintain high compliance standards.
McAuley went on to say "Our company is rapidly evolving into providing an integrated healthcare experience that spans from testing to treatment by combining cutting edge technologies including telemedicine and state of the art lab testing. Add to this the fact that we are now serving enterprise level clients as promised and partnering on initiatives such as our recently announced travel bubble, it's safe to say we are on the path to becoming a formidable small cap health & wellness company in 2021. I want to thank our loyal shareholders for trusting my leadership transition, welcome all of our newest shareholders and we look forward to delivering continued accelerated growth in 2021 and well beyond."
ABOUT EMPOWER:
Empower is creating a network of physicians and practitioners who integrate to serve patient needs, in-clinic, through telemedicine, and with an expanded suite of physician-based services. A simplified, streamlined care model bringing key attributes of the healthcare supply chain together, always focused on patient experience. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative in the United States. Empower recently acquired Kai Medical Laboratory, LLC as a wholly owned subsidiary with large-scale testing capability and will lead our diagnostic and scientific advancement.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer
CONTACTS:
Investors:Dustin KleinDirectordustin@svmmjcc.com720-352-1398
Investors:Steven McAuleyCEOs.mcauley@empowerclinics.com604-789-2146
Empower Clinics and Loop Insights Combine COVID-19 Testing Expertise With Venue Tracing To Create First Ever "Travel Bubble" Solution For Global Travel Industry Set To Lose $3.3 Trillion
11:41 am ET October 19, 2020 (Accesswire) Print
The Company advises that discussions are already underway with major airlines , cruise ship companies and hotel operators
VANCOUVER, BC / ACCESSWIRE / October 19, 2020 / Empower Clinics (CSE:CBDT) (OTC PINK:EPWCF) (FRA:8EC) (the "Company" or "Empower"), a vertically integrated health and wellness company serving a database of 165,000 patients through clinics in the southwest United States, a telemedicine platform and a world-class medical diagnostics laboratory, is pleased to announce a partnership with Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) to provide an end-to-end COVID-19 mitigation solution complete with venue tracing, real-time automated guest exposure notifications and frequent testing with rapid results in 15 minutes.
TRAVEL BUBBLE SOLUTION SOLVES CURRENT QUARANTINE REQUIREMENTS THAT ARE SHUTTING DOWN INTERNATIONAL TRAVEL
As a result of the COVID-19 pandemic, mandatory 14 day quarantine periods and the lack of any travel bubble solutions that could reliably track and mitigate the global spread of the virus by plane or cruise ship, countries have been forced to take drastic measures that are leading to significant damage of the global travel industry.
Specifically, as of today, travel restrictions by country are as follows:
58 countries are completely closed124 countries are partially open with MANDATORY quarantine upon arrival
(Source - https://www.ca.kayak.com/travel-restrictions)
Together, Loop and Empower have created a system built on the pillars of:
Venue tracingFrequent testing with rapid resultsReal-time reporting to ensure the travel bubble provides end-to-end protection
As the front facing part of the Travel Bubble solution, Loop Insights is a powerful Artificial Intelligence company whose industry leading venue tracing has gained significant traction towards reopening the tourism, hospitality and entertainment industries in the United States with the likes of University of Houston and the NCAA Basketball #VegasBubble, as well as, recently being recognized by TELUS as one of the most advanced IoT solutions in the world for their customers.
Empower's rapid antigen and antibody tests produce results in only 15 minutes, providing airlines, cruise ships and the 182 countries currently in full or partial shutdown with the safety and security necessary to fully reopen their borders to international travel.
Moreover, Empower owns KAI Medical Laboratory, a high-complexity CLIA and COLA accredited laboratory that provides reliable and accurate testing solutions to enterprise level clients, hospitals, medical clinics, pharmacies, and employer groups.
KAI has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing with the capacity to process 4,000 RT-PCR test specimens per day. COVID-19 RT-PCR testing is the gold standard due to its high degree of accuracy and will play an important role in the Travel Bubble solution.
Steven McAuley, Chairman and CEO of Empower Clinics stated "As we expand our efforts on the Get Back To Work testing initiative, it has become apparent that businesses of all types, large or small, private or public sector require not only fast and accurate COVID-19 testing, but also a comprehensive solution for contact tracing. Establishing a partnership with Loop, working with the RT-PCR and rapid testing capabilities of Kai Medical, allows our companies together to establish a safe and viable economic recovery solution."
Loop Insights CEO Rob Anson stated: "We have heard from stakeholders in the entertainment, travel, and hospitality industries that have stressed the importance of an end-to-end integrated solution capable of protecting employees and customers to facilitate a safe economic recovery. In partnership with Empower's rapid testing technology, Loop has established a comprehensive solution capable of establishing a travel bubble and reopening a significant portion of the global economy."
AIR CANADA ADVOCATES FOR TEST-BASED APPROACH AND DROPPING 14-DAY MANDATORY QUARANTINE
The Travel Bubble solution comes at a time when both major industry participants and economic experts are calling for solutions beyond quarantining to re-open industries and stave off economic collapse.
On October 6th, Air Canada (AC:TSX) (ACDVF:OTCQX) called for increased testing in lieu of mandatory quarantine periods,
"We believe that a test-based strategy may be a safe alternative to the 14-day quarantine"
On October 15, 2020 a panel of Canadian economists proclaimed the "economy must remain open despite second wave" or suffer the very likely outcome of bankruptcies and business closures "with hospitality, travel and tourism set for the harshest impact."
By providing testing, tracking, and real-time reporting, Loop and Empower have created a safe and secure Travel Bubble solution to allow enterprise level businesses to return to full operations, particularly those in the hospitality, travel, and live entertainment industries.
$3.3 TRILLION IN LOSSES FOR GLOBAL TOURISM INDUSTRY
Without a solution to replace the drastic travel measures currently in place around the world, the United Nations Conference on Trade and Development (UNCTAD) reported that COVID-19 may cost the world tourism sector losses of US$ 3.3 trillion.
In Canada alone, according to Statista, the Canadian tourism industry contributed close to $40 billion to the economy in 2019. This year, the COVID-19 pandemic has had devastating consequences for the industry.
Empower and Loop believe the Travel Bubble combination of frequent testing and a robust international tracing platform provides the end-to-end protection necessary to spark a strong global economic recovery.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
About Loop Insights
Loop Insights Inc. is a Vancouver-based Internet of Things ("IoT") technology company that delivers transformative artificial intelligence ("AI") automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop's products and services are backed by Amazon's Partner Network and sold through the TELUS IoT Marketplace.
ABOUT EMPOWER:
Empower is creating a network of physicians and practitioners who integrate to serve patient needs, in-clinic, through telemedicine, and with decentralized mobile delivery. A simplified, streamlined care model bringing key attributes of the healthcare supply chain together, always focused on patient experience. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative. Empower recently acquired Kai Medical Laboratory, LLC as a wholly-owned subsidiary with large-scale testing capability.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuleyChief Executive Officer
CONTACTS:
Investors:Dustin KleinDirectordustin@svmmjcc.com720-352-1398
Investors:Steven McAuleyCEOs.mcauley@empowerclinics.com604-789-2146
Hi MG, hope all is well, I like this one..059 ask (: long term hold here for me. EPWCF
Take care
GLTU
Annual shareholders meeting tomorrow
looks like we are on our way now---cant believe this has stayed so low so long!!--------tmonkey
Empower Clinics New Medical Laboratory Commences COVID-19 RT-PCR Tests for Disney Production
3:30 am ET October 7, 2020 (Accesswire) Print
Agreement demonstrates ability of newly acquired, state-of-the-art diagnostics laboratory to advance Empower COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and colleges
VANCOUVER BC / ACCESSWIRE / October 7, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") is pleased to announce that its newly acquired and wholly-owned subsidiary, Kai Medical Laboratory, LLC ("KAI"), has commenced a COVID-19 RT-PCR testing program for a Disney film & television production. The program is forecast to test 1,000 specimens over 30 days.
NEWLY ACQUIRED KAI MEDICAL LABORATORY HAS PROCESSED TESTS FOR SIX FILM AND TELEVISION PRODUCTIONS THROUGH THIS CHANNEL
On September 1, 2020, KAI entered into to a services agreement with To Dream A Life, LLC who provides coordinated COVID-19 testing services in key markets in the United States including Los Angeles, Atlanta, New York, Dallas and other major U.S. cities through their division Prevention Pods https://preventionpods.com. KAI has already processed tests for six different film and television productions through this relationship and continues to build both confidence and credibility within the industry.
SUCCESSFUL TESTING OF 1,000 SPECIMEN PROGRAM COULD LEAD TO SIGNIFICANT INCREASES IN FURTHER PROGRAMS
The Company further advises that discussions with Prevention Pods are already underway to potentially significantly expand both the number and size of testing programs for the film & television industry upon successful completion of the current 1,000 specimen program. Empower wishes to emphasize that no further transaction of any kind has been confirmed but remains cautiously optimistic given the success of the relationship to date.
"In anticipation of completing the Kai Medical acquisition, we have been nurturing significant opportunities in major industries such as film & television, supporting our Get Back To Work testing initiative" said Steven McAuley, Empower's Chairman & CEO. "Kai Medical has already created numerous testing relationships that have the potential to bring significant revenue based on their ability to provide 24-hour test result turnaround times, ensuring major industries can successfully get back to work."
FILM AND TV STUDIOS SEEK FAST AND RELIABLE TESTING SOLUTIONS TO RESUME SAFE OPERATIONS AND MITIGATE BILLIONS IN LOSSES
In 2019, Disney was the leading film studio in North America. With a record-breaking domestic box office gross of 3.8 billion U.S. dollars, the studio accounted for approximately 33 percent of that year's total box office gross in the United States and Canada, or 38 percent when taking into account the market share of 20th Century Fox, which Disney acquired early in 2019.
Total earnings at the North American box office in 2019 amounted to 11.32 billion U.S. dollars as indicated by Statistica.com.
In January 2020, the U.S. motion picture and sound recording industry employed over 456 thousand people, with several hundred thousand more in Canada, U.K. and around the world.
As a result of production closures and cinema shutdowns related to COVID-19, the majority of the industry's revenues and jobs have been temporarily lost and are now at significant risk of long-term damage if the industry is unable to find solutions that can provide for the safe resumption of operations.
Empower believes it is ideally positioned through Kai Medical Laboratory to deliver one element of the overall solution with reliable, accurate and fast 24-hour COVID-19 RT-PCR testing, which is the gold standard of testing.
ABOUT EMPOWER
Empower is an integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative. Empower recently acquired Kai Medical Laboratory, LLC as a wholly owned subsidiary.
ABOUT Kai Medical Laboratory
Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children's Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas). Kai Medical Laboratory is now a wholly owned subsidiary of Empower Clinics Inc.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuleyChief Executive Officer
CONTACTS:
Investors:Dustin KleinDirectordustin@svmmjcc.com720-352-1398
Investors:Steven McAuleyCEOs.mcauley@empowerclinics.com604-789-2146
Empower Clinics Acquires Medical Laboratory Capable of Processing 4,000 COVID-19 RT-PCR Tests Per Day
3:30 am ET October 6, 2020 (Accesswire) Print
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX, will advance Empower COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses, colleges and universities
VANCOUVER BC / ACCESSWIRE / October 6, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) ("Empower" or the "Company") is pleased to announce that, pursuant to the terms of a membership interest purchase agreement dated October 5, 2020, has completed the acquisition of Kai Medical Laboratory, LLC ("KAI") from KTM5 Holdings, LLC, NULV11, LLC and Consistent Investment Group, LLC (together, the "Vendors"), through its wholly-owned subsidiary, Empower Healthcare Assets Inc. ("Empower Health"), for consideration having an aggregate value of US$1,971,857 (CAD$2,613,478), effective as of October 5, 2020 (the "Transaction").
COVID-19 RT-PCR TESTING IS THE GOLD STANDARD THAT ALLOWS EMPOWER TO ROLL OUT NATIONAL PHASE 4 TESTING PROGRAMS
KAI Medical Laboratory operates a high-complexity CLIA and COLA accredited laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. KAI has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing with the capacity to process 4,000 RT-PCR test specimens per day. While the RT-PCR test identifies if a patient has an active virus, the serology or antibody test detects if a patient has previously been exposed to the virus. Both of these test results are vital to managing outbreaks and the potential spread of coronavirus.
As a result of this capability, Empower is now able to expand phase four of its COVID-19 testing rollout which was first announced on April 27, 2020 beginning with testing in-clinic testing (Phase 1) and culminating with a nationwide roll-out across the United States (Phase 4). Phase 4 allows Empower to service enterprise level clients, including movie and television studios that require reliable, accurate, fast and mass batch testing capabilities in order to resume production in a safe and compliant manner.
"Adding Kai Medical Laboratory to the Empower Clinics family enables us to dramatically expand COVID-19 testing capability, for our get back to work & get back to school initiatives as part of our national rollout plans" said Steven McAuley, Empower's Chairman & CEO. "Kai Medical has a newly built high-complexity lab offering a wide array of testing services, that we will leverage to serve the massive demand for national COVID testing in the U.S. Additionally, as flu season arrives and a potential second-wave of COVID takes hold, the technical infrastructure of Kai Medical allows Empower to capture testing demand and bring new technical testing products to market."
COVID-19 TESTING PROGRAMS FOR EMPLOYERS AND DIRECT TO CONSUMER ALREADY UNDERWAY AT KAI LABORATORY
To further assist with COVID-19 testing, Kai Medical Laboratory has also developed two key programs in Texas and Arizona. The first program is a direct-to-consumer program that leverages the ability of various healthcare providers to order and administer both the RT-PCR test and the Antibody test. This increases the ability of the general population to be tested, in certain circumstances. The second is an Employer COVID-19 Compliance Program (ECCP) for business owners and employer groups to enable them to test and monitor their employees.
Texas program https://www.testtexasnow.com
Arizona program https://www.covidtest2u.com
Finally, beyond its COVID-19 capabilities, Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals and pharmacists.
KAI MEDICAL LABORATORY TEAM LEAD BY YOSHI TYLER
The driving force behind Kai Medical Laboratory's remarkable growth and success is Yoshi Tyler. Yoshi has a passion for being an entrepreneur, and over time, she found her true calling in healthcare. Driven by this interest, she pursued her career in the healthcare industry for more than two decades. She held leadership positions at a Fortune 500 pharmaceutical company for over thirteen years. These leadership experiences provided her with in-depth knowledge and industry insights that helped her to lead Kai Medical Laboratory towards growth.
The Kai Medical Laboratory team includes key roles including Principal Scientist, Director of Operations, Molecular Scientist, Quality Assurance, Lab Director and other critical roles.
"Kai Medical Laboratory is inspired by science and built on integrity and joining Empower allows our highly skilled personnel and state-of-the-art instrumentation to expand from a local community level to a national level" says Yoshi Tyler, Founder of Kai Medical. "Our mission is to change healthcare through science & innovative quality care, and with Empower providing an expansion of resources, Kai Medical Laboratory will be in a position to help the national need for expanded COVID-19 testing as the second wave commences."
ADDITIONAL TERMS OF THE ACQUISITION
In connection with the closing of the Transaction (the "Closing"), Empower; (i) assumes certain short term and long term liabilities comprised of the SBA Loan of (US$1,139,577), the EIDL Loan of (US$150,000), the PPP Loan of (US$86,379), revolving debt of (US$89,478), (ii), accounts payable of (US$192,460), (iii) other short term and long term liabilities of (US$313,963), in total equal to the amount of US$1,971,857 (CAD$2,613,478), (the "Assumed Indebtedness"); the issuance of options to purchase common shares of Buyer Parent at an exercise price of CDN$0.05 per share, subject to the terms and conditions of each of the Option Agreements, in an amount equal to 400,000 share options to Yoshi Tyler, as the principal of KTM5, and 100,000 share options to Michael Haines, as the principal of NULV11 (the "Options"); and the issuance of a warrant certificate to Continuous Investment Group, LLC to purchase 500,000 common shares of Buyer Parent at a purchase price of CDN$0.05 per share, subject to the terms and conditions of the Warrant Certificate (the "Warrants").
Market Leading Technology Kai Medical Laboratory utilizes state-of-the-art instrumentation, preeminent testing methodologies, and laboratory services enabling high-complexity accredited laboratory testing solutions, providing some of the following key instrument testing capabilities:
Thermo Fisher - QuantStudio 12K FlexCOVID-19 testingCannabis TestingClinical GenomicsRoche Cobas 6000COVID-19 Antibody testingClinical Chemistry/EndocrinologyAB SCIEX 6500+ - Liquid Chromatography Mass SpectrometryClinical Chemistry/EndocrinologyAgriculture/Cannabis testingAB SCIEX 4500 - Liquid Chromatography Mass SpectrometryUrine ToxicologyCannabis testingSYSMEX XN-550Hematology
(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.
(COLA) is the premier clinical laboratory accreditation, education and consultation organization. An independent accreditor whose practical, educational standards have a positive and immediate impact on patient care. http://www.cola.org
ABOUT EMPOWER
Empower is an integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.
ABOUT Kai Medical Laboratory
Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children's Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas).
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuleyChief Executive Officer
CONTACTS:
Investors:Dustin KleinDirectordustin@svmmjcc.com720-352-1398
Investors:Steven McAuleyCEOs.mcauley@empowerclinics.com604-789-2146
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley's franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company's products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
SOURCE: EMPOWER CLINICS INC.
View source version on accesswire.com: https://www.accesswire.com/609282/Empower-Clinics-Acquires-Medical-Laboratory-Capable-of-Processing-4000-COVID-19-RT-PCR-Tests-Per-Day
Empower Clinics Expands COVID-19 Testing Programs by Commencing RT-PCR Testing
3:30 am ET September 10, 2020 (Accesswire) Print
Empower commences COVID-19 RT-PCR testing supported by Kai Medical Laboratory to process daily testing requirements as part of a "Back to Work" and "Back to School" campaign
VANCOUVER BC / ACCESSWIRE / September 10, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") today announces it has commenced COVID-19 reverse transcription polymerase chain reaction (RT-PCR), testing through its Sun Valley Health operations in Arizona, using RT-PCR test kits and laboratory test processing by Kai Medical Laboratory in Dallas, TX., the recently announced proposed acquisition target by Empower.
The programs are part of a "Back to Work" and "Back to School" initiative supported by a variety of outbound marketing campaigns including new Facebook ads, text message & email campaigns and outbound call-center campaigns targeting businesses, universities & colleges, sports teams or organizations where effective social distancing could be difficult.
RT-PCR Testing can be booked via: https://www.sunvalleyhealth.com/covid-19-test-book-now/
Currently Kai Medical Laboratory has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine.
"Launching our RT-PCR testing programs utilizing the capability of Kai Medical Labs gives us the ability to access massive testing volume not only in Arizona, but nationwide in the U.S." said Steven McAuley, Empower's Chairman & CEO. "Our team at Sun Valley Health has created numerous strategic marketing campaigns to drive awareness and testing volume, leveraging our supply chain improvements with increased profit margins."
Many schools and universities are now requiring students and teachers to provide RT-PCR testing results prior to returning to campus. Our nasal or throat swab RT-PCR testing program allow students and teachers to quickly be tested and receive results from a Clinical Laboratory Improvement Amendments (CLIA), accredited laboratory in only 24 - 48 hours.
Businesses need a stable workforce, and must be quick to isolate employees with any symptoms. Our RT-PCR testing allows employees to be tested quickly and receive results within 24 - 48 hours, giving the employee and the employer the opportunity to activate non-contagious employees and safely return to work!
Travelers are also discovering demands to get a RT-PCR test and provide the result upon check-in at the airport. The reports are required to be no more than 3 days old. Our testing program provides accurate results within 24-48 hours, giving the patient a document that can make the difference in being able to travel.
https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.html
https://www.wsj.com/articles/universities-plan-robust-covid-19-testing-for-returning-students-11594812937
An RT-PCR assay is a viral molecular test to detect active infection directly in a patient's RNA genetic sequence. An RT-PCR swab test is considered the gold-standard for testing & diagnosing active viral infections and should be used for anyone who has symptoms or known exposure to COVID-19. These tests are renowned for high sensitivity and high specificity.
(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.
USA COVID-19 Data as at September 9, 2020TOTAL CASES: 6,310,663TOTAL DEATHS: 189,147CASES IN LAST 7 DAYS: 262,971
ARIZONA as at September 9, 2020CONFIRMED CASES: 204,239PROBABLE CASES: 1,806TOTAL CASES: 206,045CASES IN LAST 7 DAYS: 3,703CASES/100K: 2,873DEATHS/100K: 72
TEXAS as at September 9, 2020TOTAL CASES: 641,791CASES IN LAST 7 DAYS: 24,458CASES/100K: 2,236DEATHS/100K: 47
ABOUT EMPOWER
Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.
ABOUT Kai Medical Laboratory
Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals, and pharmacists. https://www.kaimedicallaboratory.com
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuleyChief Executive Officer
CONTACTS:
Investors: Dustin KleinDirectordustin@svmmjcc.com720-352-1398
Investors: Steven McAuleyCEOs.mcauley@empowerclinics.com604-789-2146
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the proposed acquisition of Sun Valley; the proposed transaction terms; the expected number of clinics and patients following the closing; the future potential success of Sun Valley's franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company's products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com: https://www.accesswire.com/605506/Empower-Clinics-Expands-COVID-19-Testing-Programs-by-Commencing-RT-PCR-Testing
Empower Clinics Announces Acquisition of Medical Diagnostics Laboratory
4:00 am ET September 1, 2020 (Accesswire) Print
Empower intends to acquire Kai Medical Laboratory, a state-of-the-art diagnostics laboratory located in the medical district of Dallas, TX to advance COVID-19 national testing programs
VANCOUVER, BC / ACCESSWIRE / September 1, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) ("Empower" or the "Company") today announces it has entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC ("Kai Medical Laboratory"), by way of a share or asset acquisition, subject to due diligence and customary closing conditions.
Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals, and pharmacists. https://www.kaimedicallaboratory.com
Kai Medical Laboratory has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing. While the RT-PCR test identifies if a patient has an active virus, the serology or antibody test detects if a patient has previously been exposed to the virus. Both of these test results are vital to managing outbreaks and the potential spread of coronavirus.
To further assist with COVID-19 testing, Kai Medical Laboratory has also developed two key programs in Texas and Arizona. The first program is a direct-to-consumer program that leverages the ability of various healthcare providers to order and administer both the RT-PCR test and the Antibody test. This increases the ability of the general population to be tested, in certain circumstances. The second is an Employer COVID-19 Compliance Program (ECCP) for business owners and employer groups to enable them to test and monitor their employees.
Texas program https://www.testtexasnow.com
Arizona program https://www.covidtest2u.com
Currently the lab has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine. The lab also utilizes a Roche Cobas 6000 for COVID-19 Antibody testing, ensuring that Kai Medical Laboratory has the capability and capacity to serve a broad range of clients and test methods.
"Adding Kai Medical Laboratory to the Empower Clinics family enables us to dramatically expand COVID-19 testing capability and deliver phase four of our national rollout plan" said Steven McAuley, Empower's Chairman & CEO. "Kai Medical has a newly built high-complexity lab offering a wide array of testing services, that together we will leverage to serve the massive demand for national COVID testing in the U.S. Further, as flu season arrives and a potential second-wave of COVID takes hold, the technical infrastructure of Kai Medical allows Empower to capture testing demand and the additional growth revenues associated with it."
The driving force behind Kai Medical Laboratory's remarkable growth and success is Yoshi Tyler. Yoshi has a passion for being an entrepreneur, and overtime, she found her true calling in healthcare. Driven by this interest, she pursued her career in the healthcare industry for more than two decades. She helmed leadership positions at a Fortune 500 pharmaceutical company for over thirteen years. These leadership experiences provided her with in-depth knowledge and industry insights that helped her to lead Kai Medical Laboratory towards growth.
The Kai Medical Laboratory team includes key roles including Principal Scientist, Director of Operations, Molecular Scientist, Quality Assurance, Lab Director and other critical roles.
"Kai Medical Laboratory is inspired by science and built on integrity. Our mission is to change healthcare through science & innovative quality care by providing value-added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in healthcare," says Yoshi Tyler, the owner, and CEO of the company.
The proposed acquisition includes an 8,000 sq. ft. medical laboratory including covered drive up testing center, with premium testing and laboratory equipment, cash and current assets with a value in excess of $1,750,000.00 USD and a corporate office, both located in the heart of the medical district in Dallas, TX. Under the proposed terms Empower will assume a $1,200,000.00 USD Small Business Administration (SBA) equipment loan, a $150,000.00 SBA Economic Injury Disaster Loan and short-term liabilities of up to $250,000.00 at closing. In addition, Empower will issue 1,000,000 Company stock options to the Vendors, subject to the terms and conditions as set out in the Company Stock Option Plan.
Market Leading Technology Kai Medical Laboratory utilizes state-of-the-art instrumentation, preeminent testing methodologies, and laboratory services enabling high-complexity accredited laboratory testing solutions, providing some of the following key instrument testing capabilities:
Thermo Fisher - QuantStudio 12K FlexCOVID-19 testingCannabis TestingClinical GenomicsRoche Cobas 6000COVID-19 Antibody testingClinical Chemistry/EndocrinologyAB SCIEX 6500+ - Liquid Chromatography Mass SpectrometryClinical Chemistry/EndocrinologyAgriculture/Cannabis testingAB SCIEX 4500 - Liquid Chromatography Mass SpectrometryUrine ToxicologyCannabis testingSYSMEX XN-550Hematology
USA COVID-19 Data as at August 31, 2020
TOTAL CASES: 5,972,356
TOTAL DEATHS: 182,622
CASES IN LAST 7 DAYS: 289,865
ARIZONA as at August 31, 2020
CONFIRMED CASES: 199,984
PROBABLE CASES: 1,713
TOTAL CASES: 201,661
CASES IN LAST 7 DAYS: 3,558
CASES/100K: 1,769
DEATHS/100K: 70
TEXAS as at August 31, 2020
TOTAL CASES: 610,354
CASES IN LAST 7 DAYS: 32,817
CASES/100K: 2,126
DEATHS/100K: 46
(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.
(COLA) is the premier clinical laboratory accreditation, education and consultation organization. An independent accreditor whose practical, educational standards have a positive and immediate impact on patient care. http://www.cola.org
The transaction is expected to be structured on a tax efficient basis, and otherwise in accordance with the requirements of requisite securities laws and the policies of the CSE. Empower has agreed to enter into employment agreements with Yoshi Tyler and Michael Haines, each having an initial term of two years.
Completion of the transaction will be subject to various conditions, including entry into a definitive agreement, completion of due diligence, and receipt of all required shareholder, manager, third party and regulatory approvals, including approval of the CSE. Closing of the transaction is expected to occur prior to October 15, 2020.
ABOUT EMPOWER
Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.
ABOUT KAI MEDICAL LABORATORY
Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children's Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas).
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuleyChief Executive Officer
CONTACTS:
Investors: Dustin Klein
Directordustin@svmmjcc.com720-352-1398
Investors: Steven McAuley
CEOs.mcauley@empowerclinics.com604-789-2146
Hang in there guys. I have a theory that there’s some good (very good ?) developments coming down the line.
even with great results and more to come this ticker is gettin no love---in time pps should catch up with results---i can hold a long time and wait it out---tmonkey
We have a decent bid here
trading again today from open!!-looks like a pop at start--must be some pent up buying pressure after all these days!-----tmonkey
if they know something we dont its the only gane in town to buy down here-im in for the long term but nice to see some fast green!...seems like they are the right place at the right time and people are just finding it---tmonkey
We shall see. Average volume up big but still low. Should show up on some radars
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
460
|
Created
|
06/08/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |